Formulation and characterization of glipizide solid dosage form with enhanced solubility
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0297467 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Badriyah Shadid Alotaibi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia. Hauptthemen laut MEDLINE: Glipizide, Polyvinyls. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Princess Nourah Bint Abdulrahman University, Deanship of Graduate Studies at Ajman University.
Abstract (Originalsprache)
Glipizide, a poor water-soluble drug belongs to BCS class II. The proposed work aimed to enhance the solubility of glipizide by preparing solid dispersions, using polyvinyl pyrrolidone (PVP) and polyethylene glycol (PEG). Solvent evaporation method was used for the preparation of glipizide solid dispersions. Solid dispersions were prepared in four different drug-to-polymer ratios i.e. 1:1, 1:2, 1:3 and 1:4. Mainly effect of three polymers (PVP K30, PVP K90 and PEG 6000) was evaluated on the solubility and dissolution of glipizide. The in-vitro dissolution of all prepared formulations was performed under pH 6.8 at 37°C using USP type II apparatus. In-vitro dissolution results revealed that the formulations having high concentrations of the polymer showed enhanced solubility. Enhancements in the solubility and rate of dissolution of the drug were noted in solid dispersion formulations compared to the physical blends and pure drug. Solid dispersions containing polyvinyl pyrrolidone exhibited a more favorable pattern of drug release compared to the corresponding solid dispersions with PEG. An increase in the maximum solubility of the drug within the solid dispersion systems was observed in all instances. Two solid dispersion formulations were optimized and formulated into immediate-release tablets, which passed all the pharmacopoeial and non-pharmacopoeial tests. Fourier transformed Infrared (FTIR) spectroscopy X-ray diffraction (XRD) and Differential scanning calorimetry (DSC) were used to indicate drug: polymer interactions in solid state. Analysis of the solid dispersion samples through characterization tests indicated the compatibility between the drug and the polymer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia.
- Department of Pharmacy, COMSATS University Islamabad, Abbottabad Campus, Abbottabad, Pakistan.
- Faculty of Pharmacy, Hamdard University, Islamabad Campus, Pakistan.
- Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Ajman University, Ajman, United Arab Emirates.
- Department of Pharmacy, COMSATS University Islamabad, Lahore Campus, Lahore, Pakistan.
ORCID-Profile: Muhammad Ahsan Khan, Kaleem Ullah, Haya Yasin, Ghulam Murtaza
Förderung
- Princess Nourah Bint Abdulrahman University
- Deanship of Graduate Studies at Ajman University
Zitieren
APA
Alotaibi, B. S., Khan, M. A., Ullah, K., Yasin, H., Mannan, A., Khan, S. A., & Murtaza, G. (2024). Formulation and characterization of glipizide solid dosage form with enhanced solubility. PLOS ONE. https://doi.org/10.1371/journal.pone.0297467
Vancouver
Alotaibi BS, Khan MA, Ullah K, Yasin H, Mannan A, Khan SA, et al. Formulation and characterization of glipizide solid dosage form with enhanced solubility. PLOS ONE. 2024. doi:10.1371/journal.pone.0297467
BibTeX
@article{Alotaibi2024,
author = {Alotaibi, Badriyah Shadid and Khan, Muhammad Ahsan and Ullah, Kaleem and Yasin, Haya and Mannan, Abdul and Khan, Shujaat Ali and Murtaza, Ghulam},
title = {Formulation and characterization of glipizide solid dosage form with enhanced solubility},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0297467}
}
EUVIMED